Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.4793 per EA under NDC 00832058111. Its NADAC has been published 387 times since Jan 30, 2019.
Strength
20 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832058111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA209687On Market Since
10/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 387 times since Jan 30, 2019, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4793 per EA |
|---|---|
| All-time high | $1.8320 (Feb 13, 2019) |
| All-time low | $0.4061 (Jul 23, 2025) |
| 52-week high | $0.5144 |
| 52-week low | $0.4061 |
| Median price | $0.7083 |
| Average price | $0.7458 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 387 |
| Tracking since | Jan 30, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.4793 per EA (NDC 00832058111), effective Jun 24, 2026.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 73.8%. It has been tracked across 387 weekly CMS publications since Jan 30, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since Jan 30, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.4061 (Jul 23, 2025) to a high of $1.8320 (Feb 13, 2019), with a median of $0.7083 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 20 MG TABLET, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 00832058111) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification